Breast Cancer News and Research

Latest Breast Cancer News and Research

FDA grants clearance for first 2D digital mammography system with patient-assisted compression

Today, the U.S. Food and Drug Administration cleared the first 2D digital mammography system that allows patients to increase or decrease the amount of compression applied to their own breast before the mammogram x-ray is taken.

1 Sep 2017

New study finds lack of adherence to lifesaving treatment among breast cancer patients on opioids

A new study has found a troubling lack of adherence to a potentially lifesaving treatment regimen among breast cancer patients who take opioids to manage their pain.

1 Sep 2017

Fat may influence cancer development in diverse ways

Adipose tissue, or fat, may influence the development of cancer in diverse ways, depending on the type of fat and the location in the body.

1 Sep 2017

Beta blockers capable of reducing stress signaling may enhance effectiveness of immunotherapy

While the development of therapies designed to block "checkpoints" within the immune system has been one of the most exciting and noteworthy advances in cancer research in recent years, it's also been one of the most puzzling, leaving researchers to ask: Why don't these new therapies work for more patients, and why is their efficacy in controlling cancerous tumors often short-lived? A research team from Roswell Park Cancer Institute has shown that at least one answer - and an excellent opportunity for unleashing the full potential of these promising immunotherapies - may lie in the body's "fight or flight" reaction to stressors and in drugs already widely used to control and temporarily disable this stress response.

31 Aug 2017

New drug shows promise to treat women with estrogen positive metastatic breast cancer

Z-endoxifen, a potent derivative of the drug tamoxifen, could itself be a new treatment for the most common form of breast cancer in women with metastatic disease.

31 Aug 2017

Researchers synthesizing new, first-in-class drug to stop growth of ER-positive breast cancer

Researchers at UT Health San Antonio and two partner institutions are developing a new, first-in-class agent that has stopped the growth of estrogen receptor-positive (ER-positive) breast cancer in its tracks.

30 Aug 2017

Two-stage approach improves outcomes for women with large breasts undergoing risk-reducing mastectomy

For women undergoing risk-reducing mastectomy to prevent breast cancer, reconstruction can be challenging in those with larger breasts.

30 Aug 2017

Immunotherapy that uses existing cancer drugs in a new way delivers promising results

Immunotherapy is an emerging field in the global fight against cancer, even though scientists and clinicians have been working for decades to find ways to help the body's immune system detect and attack cancerous cells.

29 Aug 2017

Research findings potentially open door to new treatments for eye trauma and retinal disease

Cells within an injured mouse eye can be coaxed into regenerating neurons and those new neurons appear to integrate themselves into the eye's circuitry, new research shows. The findings potentially open the door to new treatments for eye trauma and retinal disease.

28 Aug 2017

Simultaneous treatment with anti-PD1 and anti-OX40 cancer therapies may have detrimental effect

Concurrent administration of the T-cell stimulating anti-OX40 antibody and the immune checkpoint inhibitor anti-PD1 antibody attenuated the effect of anti-OX40 and resulted in poor treatment outcomes in mice.

28 Aug 2017

UC San Diego researchers receive $18.2 million grant for B cell cancer clinical trial

The Independent Citizens Oversight Committee of the California Institute for Regenerative Medicine today unanimously approved an $18.29 million grant to University of California San Diego School of Medicine researchers to fund a phase Ib/IIa clinical trial of a novel combination drug therapy for B-cell cancers.

26 Aug 2017

Astex celebrates as breast cancer drug gets European marketing approval

Astex Pharmaceuticals, a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics for oncology and diseases of the central nervous system, announced today that its long-standing pharmaceutical collaborator, Novartis, has received marketing approval in Europe for Kisqali (ribociclib) plus an aromatase inhibitor as a first-line treatment in post-menopausal women with hormone receptor positive, human epidermal growth factor receptor-2 negative (HR+/HER2-) locally advanced or metastatic breast cancer.

26 Aug 2017

Writing your way through cancer

When Lynn Scozzari wrote the beginning lines of that poem, "The Offering," in 2013, she was staring at a photo of a naked woman seated on a rock, her arms thrust open to a valley below. Scozzari herself was in a conference room of the cancer center at Scripps Green Hospital in La Jolla, Calif., seated at a table stocked with coffee and tissues.

26 Aug 2017

Breast Cancer News and Research

Latest Breast Cancer News and Research

FDA grants clearance for first 2D digital mammography system with patient-assisted compression

New study finds lack of adherence to lifesaving treatment among breast cancer patients on opioids

Fat may influence cancer development in diverse ways

Beta blockers capable of reducing stress signaling may enhance effectiveness of immunotherapy

New drug shows promise to treat women with estrogen positive metastatic breast cancer

Researchers synthesizing new, first-in-class drug to stop growth of ER-positive breast cancer

Two-stage approach improves outcomes for women with large breasts undergoing risk-reducing mastectomy

Immunotherapy that uses existing cancer drugs in a new way delivers promising results

Research findings potentially open door to new treatments for eye trauma and retinal disease

Simultaneous treatment with anti-PD1 and anti-OX40 cancer therapies may have detrimental effect

UC San Diego researchers receive $18.2 million grant for B cell cancer clinical trial

Astex celebrates as breast cancer drug gets European marketing approval

Writing your way through cancer

New approach delivers drugs to cancer cells while protecting healthy tissues

First FDA-approved stem cell trial for shoulder injuries reaches full enrollment

Study provides better understanding of how estrogen regulates gene expression

Rare transition metal can simplify design and preparation of antibody therapies

New clinical trial to test cancer drug in patients with advanced solid tumors

Canadian study documents continued decline in hormone therapy usage

Dying at home in an opioid crisis: Hospices grapple with stolen meds

Forensics and toxicology - Industry Focus eBook eBook

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

Breast Cancer News and Research

Latest Breast Cancer News and Research

Forensics and toxicology - Industry Focus eBook eBook

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

Newsletters you may be interested in